Pro-urokinase for Recent Posterior Brain Strokes
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a clot-dissolving medication (pro-urokinase) for people with recent strokes in the back of the brain. You would be treated 4.5 to 9 hours after symptoms start, which is beyond the typical treatment window, using special MRI patterns to identify patients most likely to benefit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Stroke symptoms that started 4.5–9 hours ago (including strokes you noticed after waking up)
- Specific MRI findings showing the right size and pattern of brain damage
- Stroke severity score between 4 and 25 (mild to moderate symptoms)
- No major stroke disability before this one, or a previous stroke with minimal lasting effects
- Able to undergo MRI imaging and sign informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether tenecteplase (a clot-busting medication) can help patients who have had a stroke within 4.5 to 9 hours and show a specific pattern on brain MRI called DWI-FLAIR mismatch, which suggests the brain tissue may still be salvageable.
This trial tests a clot-dissolving medication called rhTNK-tPA for people who had a stroke 4.5 to 24 hours ago. It aims to help those with certain types of blockages in the brain who are still having moderate to severe symptoms.
This trial tests giving a clot-dissolving medicine (rhPro-UK) through a vein before a procedure to remove a large blood clot in the brain. It is for people who had a stroke 4.5 to 24 hours ago and are already scheduled for clot removal. The goal is to see if the medicine helps improve blood flow and outcomes.
This trial tests a medicine given through a vein to break up blood clots in medium-sized brain arteries. It may help people who had a stroke between 4.5 and 24 hours ago and cannot have the standard clot-removal procedure.
This trial tests whether the clot-busting drug urokinase can help people who have had an ischemic stroke (a stroke caused by a blood clot). The goal is to dissolve the clot and improve recovery, as long as treatment starts within 6 hours of the first symptoms.
This trial tests a clot-busting drug called recombinant human prourokinase for people having an ischemic stroke (a stroke from a blocked blood vessel). The drug is given through an IV within 4.5 hours of symptoms to help restore blood flow and potentially reduce disability.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.